Commission bids to speed up pricing decisions for new drugs

Proposal would shorten time-limit for decisions to 130 days, less for generics.

The European Commission published a proposal today designed to speed up decisions by national administrations on pricing and reimbursement of medicines. The aim is to bring new medicines to the market faster.

Please log in to read this article:

Forgot your password? Click here

Don't have a login yet?

Register for free to read this article.
It only takes a minute.